ArticleScientific reports2025
Enhancement of optical limiting activity of para-aminobenzoic acid using silver nanoparticles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
An extensive study on the laser power limiting behavior of para-aminobenzoic acid (PABA) combined with silver nanoparticles (PABA + AgNPs) was done and reported in this article. The XRD spectra for PABA + AgNPs confirm its crystalline structure. The absorption spectra of AgNPs and PABA + AgNPs indicate complete stability of the samples. However, comparison of the absorption details indicated the occurrence of bathochromic shift in the PABA + AgNPs. The band gap of PABA was reduced after the introduction of AgNPs. Further, the Z-Scan experiment indicated the occurrence of reverse saturable absorption in prepared PABA + AgNPs. The linear transmittance of probe PABA (65%) was reduced to 52% after the addition of AgNPs. The overall study supported that the addition of AgNPs was suitably helpful in increasing the optical laser limiting capabilities of PABA. The results reported herein can be helpful in synthesizing an organic-nanoparticle optical laser limiting composite material and can be employed for the safety of optically sensitive devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.